• NORTH CAROLINA SOCIETY OF GASTROENTEROLOGY
  • eedwards@meckmed.org
NCSGlogo-300NCSGlogo-only-150NCSGlogo-300NCSGlogo-300
  • Home
  • Events and Education
  • About NCSG
    • Board of Directors
    • Board Meetings
    • Grants
    • Partners
    • NCSG Bylaws
  • DONATE
JOIN or RENEW HERE
✕
Categories
  • Gastroesophageal Reflux Disease
Tags
  • Gastroesophageal Reflux Disease (GERD)

 

Study title Phathom Nerd : A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Vonoprazan 10 and 20 mg Compared to Placebo for Relief of Heartburn in Subjects with Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD) After 4 Weeks and to Evaluate the Efficacy and Safety of Vonoprazan 10 and 20 mg for Relief of Heartburn in Subjects with NERD After 6 Months
Disease or condition Non-Erosive Gastroesophageal Reflux Disease
Study type Interventional (Clinical Trial)
Intervention/treatment Vonoprazan or Placebo
Phase Phase 3
Study site University of North Carolina at Chapel Hill
Study location Chapel Hill
Principal investigator name and email Nicholas Shaheen, cedas@med.unc.edu
Study coordinator name and email Ariel Watts, ariel_watts@med.unc.edu
Phone contact 919-843-0821
Clinicaltrials.gov link https://www.clinicaltrials.gov/ct2/show/NCT05195528

 

ADDRESS


801 E Morehead Street
Suite 110
Charlotte NC 28202

LINKS


Home
Education
Events
Research
JOIN NOW

CONTACT


eedwards@meckmed.org

Copyright: North Carolina Society of Gastroenterology (NCSG)
JOIN or RENEW HERE